triazoles has been researched along with Splenic Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barozzi, P; Forghieri, F; Luppi, M; Messino, M; Morselli, M; Pecorari, M; Potenza, L; Rossi, G; Rumpianesi, F; Torelli, G; Vallerini, D | 1 |
| Cook, C; Fernandez, C; Fraser, R; McCully, B; Schmidt, M; Shouldice, E | 1 |
| Blijlevens, NM; Donnelly, JP; Klont, RR; van der Velden, WJ; Verweij, PE | 1 |
| Bäsecke, J; Glass, B; Perske, C; Rüchel, R | 1 |
| Girija, R; Hwang, YK; Joo, NH; Tan, L; Tan, P; Tee, GY | 1 |
| Vasil'eva, NN | 1 |
6 other study(ies) available for triazoles and Splenic Diseases
| Article | Year |
|---|---|
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia.
Topics: Acute Disease; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus; Caspofungin; Combined Modality Therapy; Echinocandins; Humans; Hyphae; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Leukemia, B-Cell; Lipopeptides; Male; Middle Aged; Neutropenia; Spleen; Splenectomy; Splenic Diseases; Triazoles | 2010 |
Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.
Topics: Acute Disease; Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Female; Hepatitis; Humans; Leukemia; Lung Diseases, Fungal; Opportunistic Infections; Osteomyelitis; Pyrimidines; Remission Induction; Sacroiliac Joint; Splenic Diseases; Triazoles; Voriconazole | 2003 |
Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Galactose; Graft vs Host Disease; Humans; Liver Diseases; Lymphoproliferative Disorders; Mannans; Middle Aged; Pyrimidines; Rituximab; Splenic Diseases; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
A case of pulmonary aspergillosis with lack of response to caspofungin.
Topics: Acute Disease; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Diseases; Candidiasis; Caspofungin; Combined Modality Therapy; Contraindications; Echinocandins; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hepatitis; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid; Lipopeptides; Lung Diseases, Fungal; Middle Aged; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Splenic Diseases; Triazoles; Voriconazole | 2006 |
Clinical activity of the new triazole drug voriconazole (UK 109, 496) against disseminated hepatosplenic aspergillosis in a patient with relapsed leukemia.
Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Child; Humans; Immunosuppression Therapy; Leukemia, Myeloid; Liver Diseases; Male; Pyrimidines; Splenic Diseases; Triazoles; Voriconazole | 2001 |
[A comparative evaluation of the toxic and possible carcinogenic effect of benzotriazol and phenidon].
Topics: Animals; Carcinogens; Chemical and Drug Induced Liver Injury; Female; Fibroma; Leukemia, Experimental; Lung Diseases; Lung Neoplasms; Male; Mesentery; Mice; Neoplasms, Experimental; Rats; Sarcoma, Experimental; Splenic Diseases; Triazoles | 1970 |